210 related articles for article (PubMed ID: 24659462)
1. WhatSAP - 2B4 sends mixed messages in the absence of SAP.
Watzl C; Claus M
Eur J Immunol; 2014 May; 44(5):1281-4. PubMed ID: 24659462
[TBL] [Abstract][Full Text] [Related]
2. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis.
Meazza R; Tuberosa C; Cetica V; Falco M; Parolini S; Grieve S; Griffiths GM; Sieni E; Marcenaro S; Micalizzi C; Montin D; Fagioli F; Moretta A; Mingari MC; Moretta L; Notarangelo LD; Bottino C; Aricò M; Pende D
J Allergy Clin Immunol; 2014 Dec; 134(6):1381-1387.e7. PubMed ID: 24985396
[TBL] [Abstract][Full Text] [Related]
4. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
Tangye SG; Phillips JH; Lanier LL; Nichols KE
J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
Meazza R; Falco M; Marcenaro S; Loiacono F; Canevali P; Bellora F; Tuberosa C; Locatelli F; Micalizzi C; Moretta A; Mingari MC; Moretta L; Aricò M; Bottino C; Pende D
Eur J Immunol; 2017 Jun; 47(6):1051-1061. PubMed ID: 28386908
[TBL] [Abstract][Full Text] [Related]
6. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
[TBL] [Abstract][Full Text] [Related]
7. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
Aoukaty A; Tan R
J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
[TBL] [Abstract][Full Text] [Related]
8. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
Nakajima H; Colonna M
Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
[TBL] [Abstract][Full Text] [Related]
9. 2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infection.
Pende D; Meazza R; Marcenaro S; Aricò M; Bottino C
Clin Immunol; 2019 Jul; 204():31-36. PubMed ID: 30391652
[TBL] [Abstract][Full Text] [Related]
10. NK cell regulation by SLAM family receptors and SAP-related adapters.
Veillette A
Immunol Rev; 2006 Dec; 214():22-34. PubMed ID: 17100873
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.
Ma CS; Nichols KE; Tangye SG
Annu Rev Immunol; 2007; 25():337-79. PubMed ID: 17201683
[TBL] [Abstract][Full Text] [Related]
12. Defective NK cell activation in X-linked lymphoproliferative disease.
Benoit L; Wang X; Pabst HF; Dutz J; Tan R
J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
[TBL] [Abstract][Full Text] [Related]
13. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
[TBL] [Abstract][Full Text] [Related]
14. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity.
Nakajima H; Cella M; Bouchon A; Grierson HL; Lewis J; Duckett CS; Cohen JI; Colonna M
Eur J Immunol; 2000 Nov; 30(11):3309-18. PubMed ID: 11093147
[TBL] [Abstract][Full Text] [Related]
15. NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.
Lee JE; Lim SA; Kim TJ; Kim K; Ng J; Kim YH; Jang IJ; Oh SB; Lee JC; Yee C; Kumar V; Lee KM
Eur J Immunol; 2014 Jun; 44(6):1802-13. PubMed ID: 24610736
[TBL] [Abstract][Full Text] [Related]
16. Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells.
Endt J; Eissmann P; Hoffmann SC; Meinke S; Giese T; Watzl C
Eur J Immunol; 2007 Jan; 37(1):193-8. PubMed ID: 17171759
[TBL] [Abstract][Full Text] [Related]
17. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
[TBL] [Abstract][Full Text] [Related]
18. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease.
Aoukaty A; Tan R
J Immunol; 2005 Apr; 174(8):4551-8. PubMed ID: 15814676
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).
Eissmann P; Beauchamp L; Wooters J; Tilton JC; Long EO; Watzl C
Blood; 2005 Jun; 105(12):4722-9. PubMed ID: 15713798
[TBL] [Abstract][Full Text] [Related]
20. Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.
Vaidya SV; Mathew PA
Immunol Lett; 2006 Jun; 105(2):180-4. PubMed ID: 16621032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
